Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Alpha-1-proteinase inhibitor (human)

Australian Public Assessment Report

AusPAR

AusPAR: Alpha-1-proteinase inhibitor (human) [PDF, 614.1 KB]

AusPAR: Alpha-1-proteinase inhibitor (human) [DOCX, 663.53 KB]

Attachment: Product Information: Alpha-1-proteinase inhibitor (human) [PDF, 222.84 KB]

Attachment: Product Information: Alpha-1-proteinase inhibitor (human) [DOCX, 111.82 KB]

Attachment: Extract from Clinical Evaluation Report: Alpha-1-proteinase inhibitor (human) [PDF, 1.54 MB]

Attachment: Extract from Clinical Evaluation Report: Alpha-1-proteinase inhibitor (human) [DOCX, 1.41 MB]

Device/Product Name

Prolastin®-C

Active ingredients

Alpha-1-proteinase inhibitor (human)

AusPAR Date

14 October 2016

Published

1 November 2017

Submission Number

PM-2014-04721-1-5

Submission Type

New biological entity

Decision

Approved

Product types

Prescription medicines